NCT07753525

Brief Summary

The aim of this study is to evaluate wound healing after the application of the Tooth Collar Technique (TCT) for bone augmentation in the upper or lower jaw. This technique is designed to promote tension-free wound closure and to reduce the risk of wound dehiscence. Augmentation is performed under local anesthesia. The gingiva is opened according to the TCT, after which the bone defect is reconstructed with standard biomaterials and covered with a membrane. No experimental materials are used- only a modified incision technique.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
23mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2026

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 7, 2026

Completed
25 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2028

5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

August 7, 2026

Status Verified

March 1, 2026

Enrollment Period

1.5 years

First QC Date

March 2, 2026

Last Update Submit

August 5, 2026

Conditions

Keywords

Implant surgerywound dehiscenceTooth Collar Techniqueflap designridge augmentationbone regenerationwound closure

Outcome Measures

Primary Outcomes (4)

  • early wound dehiscence

    Incidence of early wound dehiscence (yes/no) at the crest of the surgical site

    within 14 days after augmentation

  • Early Wound dehiscence

    Documentation of location of wound dehiscence (if there is wound dehiscence) with clinical photo

    within 14 days after augmentation

  • primary wound healing

    quality of primary wound healing using Wound Healing Index (WHI) of PMID16253095 ( score 1 = uneventful healing with nogingival edema, erythema, suppuration, patient dis-comfort, or flap dehiscence; score 2 = uneventfulhealing with slight gingival edema, erythema, patientdiscomfort, or flap dehiscence, but no suppuration;and score 3 = poor wound healing with significantgingival edema, erythema, patient discomfort, flapdehiscence, or any suppuration.)

    within 14 days after augmentation

  • Early Wound dehiscence

    Measurement of maximal defect dimension ( in case of wound dehiscence; with periodontal probe; in mm)

    within 14 days after augmentation

Secondary Outcomes (7)

  • soft tissue healing quality

    day 7, 14, 30 and 120 after augmentation

  • Need for -re-intervantions

    within 30 days after augmentation

  • incidence of post-operative infection

    within 30 days after augmentation

  • Gingival condition

    at 4 months after augmentation

  • Procedural parameters: closure tension

    immediately after surgery

  • +2 more secondary outcomes

Study Arms (1)

Tooth Collar Technique

EXPERIMENTAL

Participants of the study will receive surgery using the Tooth Collar Technique prior to ridge augmentation.

Procedure: Tooth Collar Technique

Interventions

During surgery, the gingiva will be opened using tooth collar technique instead of standard flap designs; after which the bone defect is augmented using standard biomaterials and covered with a membrane.

Also known as: TCTechnique
Tooth Collar Technique

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Voluntary written informed consent of the participant or their legal authorized representative has been obtained prior to any screening procedures
  • At least 18 years of age at the time of signing the Informed Consent Form (ICF)
  • Indication for horizontal and/or vertical bone augmentation in the maxilla or mandible in preparation for implant placement
  • Sufficient general health to undergo elective oral surgical procedures, as judgjed by the investigator
  • Ability and willingness to attend all study visits and comply with the protocol requirements.

You may not qualify if:

  • Current smoking or use of other nicotine-containing products (eg, e-cigarettes, chewing tobacco)
  • Presence of uncontrolled systemic diseases that may compromise healing
  • Ongoing chemotherapy, radiotherapy, or bisposphonate/anti-resorptive therapy in the head or neck region
  • History of radiation therapy to the jaws
  • active or untreated periodontal disease, caries or poor oral hygiene
  • Poorly fitting restorations on teeth adjacent to the augmentation site
  • Known allergy or hypersensitivity to any material used in the augmentation procedure.
  • Pregnant or breastfeeding women, or women planning pregnancy during the study period.
  • Participation in another interventional clinical study within the last 30 days
  • Any other condition or circumstance that, in the opinion of the investigator, could compromise participant safety, compliance, or the validity of the study results.
  • Participation in an interventional study with an investigational medicinal product or device.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

ParoPlus Aalst

Aalst, Oost-Vlaanderen, 9300, Belgium

Location

Radix Dental

Heist-op-den-Berg, Vlaams Brabant, 2220, Belgium

Location

Parodontologie & Implantologie Merchtem

Merchtem, Vlaams Brabant, 1785, Belgium

Location

UZ Leuven

Leuven, 3000, Belgium

Location

Study Officials

  • Ana B Castro, Professor

    UZLeuven, department of Oral Health Sciences, Periodontology

    PRINCIPAL INVESTIGATOR
  • Andy Temmerman, Professor

    ParoPlus Aalst

    PRINCIPAL INVESTIGATOR
  • Lorenz Seyssens, Dr

    ParoPlus Aalst

    PRINCIPAL INVESTIGATOR
  • Rutger Dhondt, Dr.

    Radix Dental

    PRINCIPAL INVESTIGATOR
  • Alexander De Greef, Drs

    Parodontologie & Implantologie Merchtem

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ana B Castro Sarda, Professor

CONTACT

Lieve Desmet, secretary

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This is a prospective, multicenter, single-arm case series conducted at four clinical centers in Belgium
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2026

First Posted

August 7, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

March 1, 2028

Study Completion (Estimated)

August 1, 2028

Last Updated

August 7, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations